Status:
COMPLETED
Effects of Exercise Intervention on Insulin Levels in Breast Cancer Survivors
Lead Sponsor:
Dana-Farber Cancer Institute
Conditions:
Breast Cancer
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to determine whether an exercise program comprised of strength and endurance training will lower fasting insulin levels in a group of breast cancer survivors. Insulin may ...
Detailed Description
* All women taking part in this study will take part in an exercise program. Group A will start exercising immediately and Group B wil have a delay period of 16 weeks before starting to exercise so in...
Eligibility Criteria
Inclusion
- History of pathologically confirmed stage I-IIIa invasive breast cancer
- Adjuvant chemotherapy and/or radiation must be completed at least 3 months prior to enrollment
- Body mass index \> 25 and/or a body composition analysis of \>30
Exclusion
- Patients taking herceptin
- Evidence of residual or distant disease
- Use of any medication expected to affect insulin levels
- Baseline exercise of more than 20 minutes two times per week
- Active malignancy
- Diabetes mellitus
- Heart disease or uncontrolled hypertension
- Presence of any condition that might be expected to impact a participant's ability to perform physical activity
Key Trial Info
Start Date :
December 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2008
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00153894
Start Date
December 1 2003
End Date
February 1 2008
Last Update
June 27 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dana Farber Cancer Institute
Boston, Massachusetts, United States, 02115